Best Practices for Operating at the Intersection of Cost, Quality and Outcomes

By AHRMM

In this four part webinar series, AHRMM explores how supply chain leaders can transform CQO from a concept into a strategy. Each 30 minute webinar will dive into a different best practice including capturing and applying alternative data sets, establishing a clinically integrated supply chain, and creating an outcomes-based contracting strategy.

In the first webinar, you will learn why supply chain needs to evolve in the value-based care environment and the steps to become a clinically integrated supply chain. The second webinar breaks down new metrics that can be used to measure and improve upon CQO while walking through a supportive detailed example.

In the third webinar, hear from a physician as she discusses how to create a clinically integrated culture with physician engagement through a physician-led value analysis program. The final webinar takes contracting to the next level by looking at how to know if your organization is ready for outcomes-based contracting and a test model to follow when implementing the strategy. View all sessions or only one at your convenience.

This webinar series is presented by AHRMM’s CQO Movement sponsor, Nexera, Inc. 

nexera-160.png

Sponsors

  • Nexera

Related Resources

Webcast
In this AHRMM webcast, Karen Morlan, administrative director of supply chain operations at Vanderbilt University Medical Center (VUMC), expla
Toolkits/Methodology
With significant pressures on hospitals and healthcare systems, it is incumbent upon those who recognize the benefits of UDI to build the business
Guides and Reports
Overview: The Business Case for the UDI work group, a formal work group of the Association for Healthcare Resource & Materials Manage
Webcast
This short webcast will give you a brief overview of the current ISM® Report On Business, share details surrounding the development of the new
Webcast
In this AHRMM webcast, Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the val